Reproductive Toxicology · Nov 20, 2026
Taurine Protects Against Paclitaxel-Induced Testicular Injury in Adult Rats by Mitigating Oxidative Stress and Apoptotic Cell Death
By Ali SK, Soliman RHM, Hassan NH et al.
Objective To evaluate the protective effects of taurine against paclitaxel-induced testicular, hormonal, metabolic, and molecular alterations in male rats. Methods Adult male rats were randomly allocated into four groups (n = 8 per group): control, taurine alone (150 mg/kg/day), paclitaxel alone (2 mg/kg every other day), and paclitaxel plus taurine. Sperm parameters, serum reproductive hormones (testosterone, FSH, and LH), and metabolic markers (glucose and cholesterol) were measured. Testicular oxidative stress was evaluated by determining malondialdehyde (MDA), superoxide dismutase (SOD), and glutathione peroxidase (GSH-Px) levels. At the same time, the inflammatory status was assessed by measuring tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β). In addition, the mRNA expression levels of apoptosis-related genes (BCL-2 and P53) and the steroidogenic gene STAR were quantified by quantitative real-time polymerase chain reaction (qRT-PCR). Testicular histopathological changes were assessed using the Johnsen scoring system. Results Paclitaxel reduced sperm motility by 57.7%, increased abnormal forms by 188%, and lowered epididymal sperm number by 42.9% and testosterone by 54.1%. It raised glucose (186%) and cholesterol (48.2%), tripled testicular MDA, reduced SOD and GSH-Px by 58–61%, elevated TNF-α and IL-1β, downregulated BCL-2 and STAR, upregulated P53, and lowered Johnsen scores from 10.00 to 4.00 (P < 0.001 for all). Taurine alone did not alter sperm parameters, hormones, MDA, cytokines, or gene expression, but modestly lowered glucose and SOD levels and raised GSH-Px activity. Co-administered with paclitaxel, taurine improved motility (56.93%), testosterone (3.64 ng/mL), glucose (147.0 mg/dL), MDA (0.81 nmol/mg protein), caspase-3 and PCNA staining, and Johnsen scores (9.00) (P < 0.05 vs. paclitaxel). It normalized P53 and partially restored BCL-2, STAR, SOD, and IL-1β, and several variables remained different from the control. Conclusion At 150 mg/kg/day (i.p.), taurine co-administered with paclitaxel attenuated testicular and metabolic toxicity through antioxidant, anti-inflammatory, and anti-apoptotic mechanisms, whereas taurine alone conferred no reproductive benefit. These findings support its potential as an adjuvant for preserving male reproductive function during chemotherapy and warrant dose-response and tumor-efficacy studies.
doi.org/10.1016/j.reprotox.2026.109417PubMed 43064258Interventions